These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36594872)

  • 1. A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery.
    He Z; Xiang W; Fan Q; Wang L; Chao J
    Chem Commun (Camb); 2023 Jan; 59(7):912-915. PubMed ID: 36594872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
    Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents.
    Qu Y; Zhang C; Ma X; Gao Y; Liu J; Wu L
    Bioorg Med Chem; 2020 Dec; 28(24):115821. PubMed ID: 33091789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitro.
    Jaffar M; Phillips RM; Williams KJ; Mrema I; Cole C; Wind NS; Ward TH; Stratford IJ; Patterson AV
    Biochem Pharmacol; 2003 Oct; 66(7):1199-206. PubMed ID: 14505799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Carbon-Carbon Bond Cleavage-Based Prodrug Activation Strategy Applied to β-Lapachone for Cancer-Specific Targeting.
    Gong Q; Li X; Li T; Wu X; Hu J; Yang F; Zhang X
    Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202210001. PubMed ID: 35938884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation.
    Zhang C; Qu Y; Ma X; Li M; Li S; Li Y; Wu L
    Bioorg Chem; 2020 Oct; 103():104200. PubMed ID: 32890998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system.
    Volpato M; Abou-Zeid N; Tanner RW; Glassbrook LT; Taylor J; Stratford I; Loadman PM; Jaffar M; Phillips RM
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3122-30. PubMed ID: 18089707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-enabled delivery of NQO1 bioactivatable drugs.
    Ma X; Moore ZR; Huang G; Huang X; Boothman DA; Gao J
    J Drug Target; 2015; 23(7-8):672-80. PubMed ID: 26453163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
    Miao D; Yu Y; Chen Y; Liu Y; Su G
    Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene prodrugs: targeting through cleavage by NQO1 (DT-diaphorase).
    Schäfer A; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1944-7. PubMed ID: 24666648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
    Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
    J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin.
    Schutt C; Ibsen S; Zahavy E; Aryal S; Kuo S; Esener S; Berns M; Esener S
    Pharm Res; 2017 Oct; 34(10):2025-2035. PubMed ID: 28791550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
    Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
    Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
    Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
    Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-Triggered Disassembly of Polymeric Micelles by Controlled Depolymerization via Cascade Cyclization for Anticancer Drug Delivery.
    Park J; Jo S; Lee YM; Saravanakumar G; Lee J; Park D; Kim WJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8060-8070. PubMed ID: 33576220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
    Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
    Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
    [TBL] [